Last Updated: September 24, 2026

RALDESY Drug Patent Profile

Name: RALDESY Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Raldesy, and what generic alternatives are available?

Raldesy is a drug marketed by Kamat and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in RALDESY is trazodone hydrochloride. There is one drug master file entry for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Raldesy

A generic version of RALDESY was approved as trazodone hydrochloride by APOTEX on March 25^th, 1987.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for RALDESY?
What are the global sales for RALDESY?
What is Average Wholesale Price for RALDESY?

Summary for RALDESY

US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Patent Applications:	1,998
Drug Prices:	Drug price information for RALDESY
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for RALDESY
What excipients (inactive ingredients) are in RALDESY?	RALDESY excipients list
DailyMed Link:	RALDESY at DailyMed

Drug patent expirations by year for RALDESY

Pharmacology for RALDESY

Drug Class	Serotonin Reuptake Inhibitor

Paragraph IV (Patent) Challenges for RALDESY

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
RALDESY	Oral Solution	trazodone hydrochloride	10 mg/mL	218637	1	2026-06-17

US Patents and Regulatory Information for RALDESY

RALDESY is protected by one US patents.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kamat	RALDESY	trazodone hydrochloride	SOLUTION;ORAL	218637-001	Nov 26, 2024		RX	Yes	Yes	8,133,893	⤷ Start Trial	Y	Y		⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for RALDESY

See the table below for patents covering RALDESY around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Argentina	067773		⤷ Start Trial
Australia	2008285779		⤷ Start Trial
Brazil	PI0814448		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.